Baxter International Inc. vs. Beta Bionics, Inc. Common Stock
Baxter International Inc. (BAX) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| BAX | BBNX | |
|---|---|---|
| Market Cap | $12.26 billion | $997.87 million |
| Revenue (TTM) | $11.47 billion | — |
| Net Income (TTM) | $-1,063,000,000 | — |
BAX leads on 1 of 1 size & scale factors.
Valuation
| BAX | BBNX | |
|---|---|---|
| Price / Book | 1.98 | 3.89 |
| Price / Sales | 1.07 | — |
BAX leads on 1 of 1 valuation factors.
Profitability
| BAX | BBNX | |
|---|---|---|
| Net Margin | -9.27% | — |
| Return on Equity | -17.20% | — |
BAX and BBNX split the profitability factors evenly.
Dividend
| BAX | BBNX | |
|---|---|---|
| Dividend Yield | 0.17% | — |
BAX and BBNX split the dividend factors evenly.
Risk & Sentiment
| BAX | BBNX | |
|---|---|---|
| Short Interest | 1.03% | 0.47% |
BBNX leads on 1 of 1 risk & sentiment factors.
Dig deeper: BAX overview, BAX financials, BBNX overview, BBNX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.